glp-1 diarrhea class action in louisiana At least 3,000 patients have filed lawsuits against the companies behind GLP -1 weight loss drugs, alleging severe health risks, including blindness. NewsNation's Brooke Shafer has the story on "Morning America." Louisiana spent over $1B on

Mechanisms of muscle loss associated with GLP-1RAs treatment Preservation of skeletal muscle is critical for metabolic health, physical function and long-term outcomes, making the study of mechanisms underlying muscle loss during GLP-1RA therapy clinically relevant

Williams and Ro will lead a multi-year campaign to normalize the use of GLP-1 medications for weight loss and support others on their health journeys

However, SGLT-2 inhibitors are also expected to be present in human milk for they are excreted in milk in animal studies (52)

FDA approvals for obesity indications have substantially expanded the addressable patient population beyond diabetes, creating unprecedented commercial opportunities

Bottom line - it is increasingly clear that #cancers #DarkGenome-derived (or #JunkDNA- derived) non-canonical proteins, also termed cancers #Dark #Matter, play a role in cancers development and can serve as targets for destructive anti-cancer immune responses

The logistical problems could lead to even more time off the medications